rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Neumora Therapeutics, Inc.

NMRA · Nasdaq

Health CareBiotechnologyNot moving yet

NMRA stood above a rising 150-day average in 23 of the last 52 weekly readings, and has been out of that trend for the last 24 weeks. It is 70.6% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 24
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$15.0M
Insider sales, 12 months
$1.9M
Officials’ trades on record
0
Institutions holding
109 (+4)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 23 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$14.4MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months3
Sale orders, 12 months10
Buyers · sellers3 · 4
WhoDidSharesTraded
Daljit Singh AuroraOfficersold20,553at $1.5921 Aug 2026filed 21 Aug 2026
Daljit Singh AuroraOfficersold21,055at $1.6021 Aug 2026filed 21 Aug 2026
Daljit Singh AuroraOfficersold67,741at $1.5120 Aug 2026filed 21 Aug 2026
Daljit Singh AuroraOfficersold66,711at $1.5120 Aug 2026filed 21 Aug 2026
Daljit Singh AuroraOfficersold31,000at $1.6519 Aug 2026filed 19 Aug 2026
Daljit Singh AuroraOfficersold30,918at $1.6519 Aug 2026filed 19 Aug 2026
Daljit Singh AuroraOfficersold34,162at $1.5818 Aug 2026filed 19 Aug 2026
Daljit Singh AuroraOfficersold34,987at $1.5918 Aug 2026filed 19 Aug 2026
Daljit Singh AuroraOfficersold57,670at $1.5117 Aug 2026filed 19 Aug 2026
Daljit Singh AuroraOfficersold34,020at $1.4917 Aug 2026filed 19 Aug 2026
Daljit Singh AuroraOfficersold55,016at $1.5017 Aug 2026filed 19 Aug 2026
Michael Lee MilliganOfficersold1,436at $3.5717 Feb 2026filed 19 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders109+4 on the quarter
New · exited29 · 25
Reported value$129.1M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Siren, L.L.C.unchanged · filed 13 Aug 20268,497,822$14.4M00.0%
BlackRock, Inc.added · filed 7 Aug 20267,791,869$13.2M+5,737,553+279.3%
SOFTBANK GROUP CORP.unchanged · filed 14 Aug 20266,090,301$10.4M00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20264,669,585$7.9M+777,692+20.0%
MIC Capital Management UK LLPunchanged · filed 10 Aug 20264,460,700$7.6M00.0%
FMR LLCadded · filed 13 Aug 20263,498,869$5.9M+2110.0%
WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUSTunchanged · filed 9 Jul 20263,309,123$5.6M00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20262,607,289$4.4M+1,520,424+139.9%
ICONIQ Capital, LLCunchanged · filed 13 Aug 20262,559,090$4.4M00.0%
TWO SIGMA INVESTMENTS, LPadded · filed 14 Aug 20262,244,829$3.8M+208,137+10.2%
30 Sep 2023 – 30 Jun 2026
3980120Sep 23Jun 24Mar 25Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Daljit Singh Aurora Company insiderOfficer · last 21 Aug 20260 · 8
Jason Duncan Company insiderOfficer · last 20 Aug 20260 · 0
Joshua Pinto Company insiderPresident & CEO · last 20 Aug 20260 · 6
Michael Lee Milligan Company insiderOfficer · last 20 Aug 20260 · 2
Paul L. Berns Company insiderDirector, Officer · last 20 Aug 20260 · 2
Alaa Halawa Company insiderDirector · last 27 May 20260 · 0
David Piacquad Company insiderDirector · last 27 May 20260 · 0
Kristina Burow Company insiderDirector, 10% owner · last 27 May 202616 · 0
Matthew K. Fust Company insiderDirector · last 27 May 20260 · 2
Maykin Ho Company insiderDirector · last 27 May 20260 · 0
Arch Venture Partners Viii, Llc Company insider10% owner · last 27 Oct 20252 · 0
ARCH Venture Partners XII, LLC Company insider10% owner · last 27 Oct 20254 · 0

Same industry

MRNA ModernaLeading+147%
ENTX Entera BioLeading+37%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-152%
Debt to equityFY 2025 · to 31 Dec 20251.10×
Share count trendFY 2025 · to 23 Mar 20264.5%
Cash and equivalentsFY 2025 · to 31 Dec 2025$182.5M

Analyst forecasts

No analyst forecasts yet.